Zhou H[au] - Search Results

Year	Number of Results
1979	1
1980	3
1981	3
1982	6
1983	3
1984	5
1985	9
1986	15
1987	14
1988	13
1989	24
1990	31
1991	25
1992	30
1993	40
1994	34
1995	66
1996	76
1997	107
1998	108
1999	122
2000	139
2001	180
2002	197
2003	249
2004	327
2005	425
2006	486
2007	571
2008	628
2009	756
2010	826
2011	948
2012	1062
2013	1257
2014	1419
2015	1587
2016	1720
2017	1883
2018	2135
2019	2447
2020	3021
2021	2051

1

[Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.

Zhou H, Zhang M, Yuan H, Zheng W, Meng C, Zhao D. Zhou H, et al. Oncol Rep. 2021 Aug;46(2):179. doi: 10.3892/or.2021.8130. Epub 2021 Jul 19. Oncol Rep. 2021. PMID: 34278509 Free PMC article.

2

miR-429 promotes the proliferation of non-small cell lung cancer cells via targeting DLC-1.

Xiao P, Liu W, Zhou H. Xiao P, et al. Among authors: zhou h. Oncol Lett. 2021 Jul;22(1):545. doi: 10.3892/ol.2021.12806. Epub 2021 May 24. Oncol Lett. 2021. PMID: 34093767 Free PMC article.

3

[Retracted] miR‑200b inhibits migration and invasion in non‑small cell lung cancer cells via targeting FSCN1.

Xiao P, Liu W, Zhou H. Xiao P, et al. Among authors: zhou h. Mol Med Rep. 2021 Aug;24(2):579. doi: 10.3892/mmr.2021.12218. Epub 2021 Jun 16. Mol Med Rep. 2021. PMID: 34132372 Free PMC article.

4

[Retracted] MicroRNA‑138 inhibits migration and invasion of non‑small cell lung cancer cells by targeting LIMK1.

Tan Y, Hu H, Tan W, Jin L, Liu J, Zhou H. Tan Y, et al. Among authors: zhou h. Mol Med Rep. 2021 Aug;24(2):570. doi: 10.3892/mmr.2021.12209. Epub 2021 Jun 10. Mol Med Rep. 2021. PMID: 34109433 Free PMC article.

5

Eshelby untwisting.

Zhong X , Zhou H , Li C , Shtukenberg AG , Ward MD , Kahr B . Zhong X , et al. Among authors: zhou h. Chem Commun (Camb). 2021 Jun 7;57(45):5538-5541. doi: 10.1039/d1cc01431e. Epub 2021 May 7. Chem Commun (Camb). 2021. PMID: 33960341

6

Retraction notice to <Recruitment of Tiam1 to Semaphorin 4D activates Rac and enhances proliferation, invasion and metastasis in oral squamous cell carcinoma> <[Neoplasia 19 (2016) 65-74]>

Zhou H, Kann MG, Mallory EK, Yang YH, Bugshan A, Binmadi NO, Basile JR. Zhou H, et al. Neoplasia. 2021 Aug;23(8):835. doi: 10.1016/j.neo.2021.07.003. Neoplasia. 2021. PMID: 34281687 Free article. No abstract available.

7

Ferritinophagy and ferroptosis in the management of metabolic diseases.

Ajoolabady A, Aslkhodapasandhokmabad H, Libby P, Tuomilehto J, Lip GYH, Penninger JM, Richardson DR, Tang D, Zhou H, Wang S, Klionsky DJ, Kroemer G, Ren J. Ajoolabady A, et al. Among authors: zhou h. Trends Endocrinol Metab. 2021 Jul;32(7):444-462. doi: 10.1016/j.tem.2021.04.010. Epub 2021 May 15. Trends Endocrinol Metab. 2021. PMID: 34006412 Review.

8

Supramolecular Antagonists Promote Mitochondrial Dysfunction.

Li M, Song Y, Song N, Wu G, Zhou H, Long J, Zhang P, Shi L, Yu Z. Li M, et al. Among authors: zhou h. Nano Lett. 2021 Jul 14;21(13):5730-5737. doi: 10.1021/acs.nanolett.1c01469. Epub 2021 Jun 18. Nano Lett. 2021. PMID: 34142834

9

JPEG Robust Invertible Grayscale.

Liu K, Chen D, Liao J, Zhang W, Zhou H, Zhang J, Zhou W, Yu N. Liu K, et al. Among authors: zhou h. IEEE Trans Vis Comput Graph. 2021 Jun 11;PP. doi: 10.1109/TVCG.2021.3088531. Online ahead of print. IEEE Trans Vis Comput Graph. 2021. PMID: 34115588

10

Donor and Recipient Age-Mismatches: The Potential of Transferring Senescence.

Iske J, Matsunaga T, Zhou H, Tullius SG. Iske J, et al. Among authors: zhou h. Front Immunol. 2021 Apr 28;12:671479. doi: 10.3389/fimmu.2021.671479. eCollection 2021. Front Immunol. 2021. PMID: 33995411 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results